This inventor holds 7 USPTO granted patents. Top assignee: University of California. Active years: 2007-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2012
Title: Innovations of Artem Valentinovich Khlebnikov
Introduction
Artem Valentinovich Khlebnikov is a prominent inventor based in Mountain View, CA (US). He has made significant contributions to the field of biotechnology, particularly in the production of isoprenoid compounds. With a total of 7 patents to his name, Khlebnikov's work has advanced the understanding and application of metabolic pathways in microorganisms.
Latest Patents
Khlebnikov's latest patents focus on methods for synthesizing isopentenyl pyrophosphate. One method involves introducing a plurality of heterologous nucleic acid sequences into a host microorganism, each coding for a different enzyme in the mevalonate pathway. Another related method introduces an intermediate in the mevalonate pathway along with at least one heterologous nucleic acid sequence necessary for converting the intermediate into isopentenyl pyrophosphate. His inventions also encompass nucleic acid sequences, enzymes, expression vectors, and transformed host cells for executing these methods.
Career Highlights
Khlebnikov is affiliated with the University of California, where he continues to push the boundaries of research in synthetic biology. His innovative approaches have garnered attention in the scientific community, leading to advancements in the production of valuable compounds through engineered microorganisms.
Collaborations
Some of Khlebnikov's notable coworkers include Jay D Keasling and Douglas J Pitera. Their collaborative efforts have further enhanced the impact of their research in the field.
Conclusion
Artem Valentinovich Khlebnikov's contributions to biotechnology and his innovative patents have positioned him as a key figure in the development of methods for synthesizing isoprenoid compounds. His work continues to inspire advancements in synthetic biology and metabolic engineering.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
